Mark Strobeck

CIK 1599219 · President and CEO · last filed 2026-04-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.04M

Companies

4

Total Filings

43

Lifetime Open-Market Net

-$989.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RMTI President and CEO 323,493 $0.62 $202.1K -$39.5K 14 2026-04-17
WINT Director 2,300 $0.01 $33 $0 1 2023-08-25
ASRT EVP & Chief Operating Officer 248,599 $23.48 $5.84M $0 1 2020-05-22
Zyla Life Sciences (EGLT) Delisted Chief Operating Officer 317,080 -$949.5K 21 2018-06-15

Recent Filings · Page 2 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-03-19 RMTI Tax (F) −6,101 -$8.5K EDGAR
2024-03-15 RMTI Grant (A) +100,000 $0 EDGAR
2023-08-25 WINT Grant (A) +2,300 $0 EDGAR
2023-03-21 RMTI Grant (A) +55,465 $0 EDGAR
2022-07-05 RMTI Grant (A) $0 EDGAR
2020-05-22 ASRT Grant (A) +248,599 $0 EDGAR
2020-05-21 Disp (D) −180,864 $0
2020-03-26 Mixed +44,962 $71.9K
2020-03-05 Grant (A) +79,800 $0
2020-03-02 Mixed +54,923 $82.4K
Showing 1120 of 43
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.